The kinetics of synthcsis and the naturc of the oligosaccharidcs of the glycoprotcins of pneumonia virus of mice (PVM) wcrc studied. Tryptic pcptidc mapping showed that the two major glycosylatcd polypcptidcs G 1 and G2 wcrc different forms of the samc protein, G2 was dcrivcd from GI which in turn appeared to bc dcrivcd from an unidentificd precursor. The G I/G2 protein of PVM is probably a hacmagglutinin since a monoclonal antibody directed against it has a high hacmagglutination inhibition titrc. On the basis of experiments with inhibitors and glycosidases it was dcduccd that G I and G2 havc both N-linkcd and O-linkcd oligosaccharides. Thc putative fusion protcin-cquivalent of PVM was shown to posscss N-linked oligosaccharidcs. In thc presence of tunicamycin a high mobility form (Fit) appcarcd to bc dcrivcd from a prccursor (F0t) with the samc mobility as the fully glycosylatcd protein. If by analogy with other paramyxoviruscs this rcprcscnts a clcavagc event, thc difference in mobility of the prccursor and product suggcsts that thc putative F2 product is smaller than thc corresponding F2 protein of other paramyxoviruscs. Howcvcr, no F2 candidate protein was detected and cvidcncc for an F 1,2 dimcr was inconclusive. The glycoproteins of PVM fcscmblc thosc of respiratory syncytial virus in terms of thcir pattern of glycosylation, but differ in their processing.
INTRODUCTION
Pneumonia virus of mice (PVM) is classified along with the human and bovine respiratory syncytial (RS) viruses and turkey rhinotracheitis (TRT) virus in the genus Pneumovirus of the family Paramvxoviridae. The accompanying paper (Ling & Pringle, 1989) describes the polypeptides identified in PVM-infected cells. The kinetics of synthesis and nature of the oligosaccharides of RS virus glycoproteins have been described in some detail by various authors (e.g. Fernie et al., 1985; Gruber & Levine, 1985a, b) . This paper describes the characterization of the oligosaccharides of the corresponding glycoproteins of PVM using tunicamycin to inhibit N-linked glycosylation and glycosidases to remove specifically N-linked and O-linked oligosaccharides. The analysis of glycoprotein processing by pulse-chase experiments in combination with immunoprecipitation by an antiglycoprotein (anti-G) monoclonal antibody (MAb) or polyclonal anti-PVM serum in the presence or absence of tunicamycin is also described.
METHODS

Propagation of cells and viruses.
The cells and virus strains used and the methods used for their growth are as described in the preceding paper (Ling & Pringle, 1989) .
MAbs. The anti-G MAb 19/1/C9 is described in the preceding paper (Ling & Pringle, 1989) . The anti-RS virus fusion (F) protein MAb 43.1 was kindly provided by Dr B. Fernie. (Ling & Pringle, 1989) . For immunoprecipitation of polypeptides from the surface of infected cells, labelled cells were incubated on ice with a 1/5 dilution of serum in phosphate-buffered 0000-8648 © 1989 SGM saline (PBS) for 30 rain. The cells were then washed five times with PBS containing 1 mM-phenylmethylsulphonyl fluoride and lysed either in high salt RIP buffer (Ling & Pringle, 1989) or in low salt RIP buffer (Ling & Pringle, 1988) .
Radiolabelling of cells and immunoprecipitation. PVM-infected cells were labelled with [35S]methionine or [3H]glucosamine as described previously
Trypticpeptide mapping. Polypeptides labelled with [35S]methionine (500 gCi/ml) and [3H]leucine (750 ~tCi/ml) were excised from dried gels using autoradiographs as templates. Tryptic peptide mapping was carried out as described by Elder et al. (1977) . The bands were washed four times for 30 min each with 25~ propan-2-ol and left overnight in 10~ methanol. The gel slices were lyophilized and incubated for 24 h at 37 °C in ammonium hydrogen carbonate buffer (0-05 M at pH 8) containing trypsin (50 pg/ml). The supernatant was lyophilized and dissolved in thin-layer electrophoresis buffer (1.5% acetic acid, 0.5~ formic acid).
Digestion of glycoproteins with glycopeptidase F and endo-ct-N-acetylgalactosaminidase. Polypeptides labelled with
[3H]glucosamine or [35S]methionine were excised from gels and eluted electrophoretically through stacking gels in I0 × 0-5 cm tubes sealed at the bottom with dialysis tubing. The gel slices were rehydrated in sample buffer (Laemmli, 1970) before elution. When the bromophenol blue entered the dialysis tubing the tubing was tied off at the top and the samples were dialysed against five changes of ammonium hydrogen carbonate (0.1 M). Samples to be digested with glycopeptidase F were incubated for 17 h at 37 °C with 20 ~1 glycopeptidase F (60 units/ml in 20 mM-EDTA, 2~ 2-mercaptoethanol, 0-5~ NP40, 0.1 ~ SDS, 200 mM-phosphate buffer pH 8.5).
Digestion with endo-ct-N-acetylgalactosaminidase (Boehringer) was carried out for 17 h at 37 °C using 1 ~tl each of endo-ct-N-acetylgalactosaminidase, neuraminidase (1 unit/ml) and mixed glycosidases from Turbo cornutus (0-1 mg/ml). The enzymes were diluted to 10 pl with 20 mM-phosphate buffer pH 6.0. Laemmli sample buffer (20 ktl) was added to the samples which were then boiled for 2 rain before analysis by SDS-PAGE.
Synthesis of PVMpolypeptides in the presence oftunicamycin. PVM-infected cells were incubated in the presence of tun~camycin (2.5 ~g/ml) at all stages following adsorption of the virus up to harvesting of the cells and supernatant samples. This concentration inhibited more than 95~ of the virus yield and less than 50~ of [35S]methionine incorporation.
Haemagglutination inhibition assay. PVM was diluted so that a further eight-fold dilution would just cause haemagglutination of murine red blood cells. Equal volumes (50 ptl) of this suspension were added to twofold antibody dilutions and 10 I11 of murine erythrocytes (109 cells) was added to each dilution. The mixtures were incubated for 2 h at room temperature and the dilution of antibody that just inhibited haemagglutination was taken as the haemagglutination inhibition titre.
RESULTS
Synthesis of the G1/G2 protein of P VM Evidence of a relationship between the G1 and G2 glycoproteins
The G 1 and G2 glycoproteins of PVM were coprecipitated by MAb 19/1/C9 (Ling & Pringle, 1989) . However, the N and/or 39K protein(s) were also sometimes coprecipitated by this antibody and the antibody did not bind in Western blots. Tryptic peptide mapping was therefore carried out to confirm a relationship between G 1 and G2. The peptides showed a similar pattern ( Fig. 1) and it was therefore concluded that the G1 and G2 polypeptides were related in some way.
The N and/or 39K polypeptides were the most heavily labelled polypeptides in infected cells which may explain their frequent appearance in immunoprecipitates of poorly labelled polypeptides. In addition, more non-specific binding of these polypeptides to immunoglobulin appeared to occur under the high salt conditions used in many of the experiments (e.g. compare 
G1 is a precursor to G2 but is not the primary translation product
Radioimmunoprecipitation using MAb 19/1/C9 was used to study the synthesis of the G 1 and G2 proteins after a short pulse label followed by incubation in medium containing no radiolabel (Fig. 2) . G1 was not detected in abundance until after 60 rain of the chase period and G2 was not detected until after 360 min of the chase period. The appearance of G2 was accompanied by a reduction in the intensity of the G 1 band so it appears that G2 is derived from G 1. No precursor to G 1 was clearly identified. The region of the gel corresponding to polypeptides with estimated Mrs of 40K to 45K was masked by coprecipitating N and/or 39K protein so that a precursor to the G protein migrating in this region of the gel would have been obscured. None of the other polypeptides observed in Fig. 2 was regularly precipitated by the 19/1/C9 MAb and therefore they were not considered to be specifically precipitated.
Forms of the PVM G glycoprotein synthesized in the presence of tunicamycin
Polypeptides synthesized in tunicamycin-treated, PVM-infected ceils and those released into the supernatant were detected by radioimmunoprecipitation. The result of [3H]glucosamine labelling and immunoprecipitation with murine anti-PVM antibody is shown in Fig, 3 . The G 1 and G2 polypeptides were not detected in tunicamycin-treated cells and two different polypeptides (G 1 t and G2t) were observed. G2t could be detected in cell lysates only when a long exposure was used (Fig. 3) . The G-related 42K polypeptide precipitated from [3H]glucosaminelabelled samples would have comigrated with the leading edge of G2t so it is not clear whether it was present in tunicamycin-treated cells. The G l t and G2t polypeptides were also immunoprecipitated from polyethylene glycol (PEG) precipitates of the supernatants of tunicamycin-treated [35S]methionine-labelled cells using MAb 19/1/C9 (data not shown).
The broad smear of label centred around 31K observed on prolonged exposure of the gels was not observed with tunicamycin-treated cells (Fig. 3) , The nature of the 31K material is not known since no amino acid-labelled protein can be associated with it, but this result suggests that it has N-linked carbohydrate.
Removal of N-linked oligosaccharides from G1 and G2 using glycopeptidase F gave polypeptides with the same mobilities as G l t and G2t respectively (Fig. 4) . G2t was not susceptible to digestion by glycopeptidase F confirming the absence of N-linked oligosaccharides from this polypeptide. G l t also appeared to be resistant to digestion by glycopeptidase F (data not shown). The nature of the higher mobility bands observed in each lane in Fig. 4 is not known.
N-linked oligosaccharides are not required for further processing of the P VM G proein
Addition of non-N-linked sugars to the G protein of PVM appears to occur since G 1 t and G2t were labelled with [3H]glucosamine as described in the previous section. In order to determine whether the kinetics of synthesis of G l t and G2t are similar to those of G1 and G2 a pulse-chase experiment with tunicamycin was carried out. Fig. 5 shows that the two forms of the G protein did appear to be processed normally, showing that N-linked oligosaccharides were not required for this processing. 
Evidence for the presence of O-linked oligosaccharides on the P V M G1 and G2 proteins
Monensin has been widely used as an inhibitor of O-linked glycosylation (e.g. Gruber & Levine, 1985a) but proved unsatisfactory for studies with PVM glycoproteins since it either did not affect or completely inhibited G-related polypeptide synthesis. G1, G2, G l t and G2t were digested with endo-~-N-acetylgalactosaminidase to identify O-linked oligosaccharides. This enzyme will only remove unsubstituted disaccharides so exoglycosidases were also included in the digestion mixtures. The glycoproteins digested with the exoglycosidases alone are shown in Fig. 6 as controls. It can be seen that each polypeptide showed a higher mobility when digested with endo-~-N-acetylgalactosaminidase and exoglycosidases than when digested with exoglycosidases alone. Digestion products are indicated by open circles, unmarked bands are breakdown products observed even in the absence of the enzymes. The estimated Mrs of the unglycosylated polypeptides are given in Table 1 
Evidence that the G1/G2 protein of PVM is the haemagglutinin
Antibodies 26/1/A2, 26/1/Ell and 26/4/C4 directed against the N or 39K, M, and 39K proteins, respectively along with three additional anti-PVM MAbs of unknown specificity did not inhibit haemagglutination (titre < 20). In contrast the anti-G1/G2 MAb 19/l/C9 strongly inhibited haemagglutination (titre 20480). This result indicates that the G1/G2 protein is the viral haemagglutinin.
Synthesis of the FI protein of PVM Synthesis of the F1 protein in the presence of tunicamycin
The F 1 protein described here has a mobility similar to that of the F 1 cleavage product of the fusion proteins of other paramyxoviruses and like them is glycosylated and expressed at the cell surface. The protein designated F1 was the major polypeptide detected on the surface of * The mobility difference due to O-linked oligosaccharides could not be determined precisely because the exoglycosidases used with the endo-N-acetylgalactosaminidase would have removed residues from both N-linked and O-linked oligosaccharides. The limits assume that all of the carbohydrate removed by exoglycosidases was Nlinked or it was all O-linked.
[35S]methionine-labelled PVM-infected cells and this aided its identification (Fig. 7a) . The 12K polypeptide also appeared to be expressed on the cell surface, but was not considered to be an F2-1ike protein because it appeared after a chase period when no change in the mobility of the F1 protein was observed (Ling & Pringle, 1989) .
The RS virus F1 protein together with polypeptides with Mr values of 22K and 12K were expressed on the surface of RS virus-infected cells. The 22K protein may represent a breakdown product of F 1 (Norrby et al., 1986) or the 22K non-glycosylated membrane protein (Routledge et al., 1987) . The 22K protein is not F2 because the F2 protein is most readily identified by [3H]glucosamine labelling and has an estimated Mr of 18K in our gel system. The PVM N and/or 39K polypeptide was also observed in some immunoprecipitations but this was found to be due to non-specific precipitation when high salt buffers were used (compare the result in Fig. 7a obtained using low salt conditions with that in Fig. 7b obtained using high salt conditions). Fig. 7 (b) shows the polypeptides observed on the surface of PVM-infected cells labelled in the presence and absence of tunicamycin. It can be seen that a polypeptide designated F i t was expressed on the surface of PVM-infected cells labelled with [35S]methionine in the presence of tunicamycin and that the F1 polypeptide was absent.
F i t is derived from a precursor
A pulse-chase experiment was carried out using tunicamycin (Fig. 8 ). It appears that F 1 t was derived from a precursor (F0t) since these bands have similar intensities and F I t appears as F0t disappears. There are no other polypeptides recognized by the antiserum that could be precursors for F l t or account for the disappearance of label from F0t. F0t may represent an unglycosylated form of an F0 protein that is cleaved to give F l t and an unidentified F2t protein. However, since no F0 protein has been identified following pulse-labelling in the absence of tunicamycin, it must be assumed if this interpretation is correct that cleavage of the glycosylated form occurs much more rapidly.
Since F0t and F1 have similar mobilities, an alternative explanation might be that F0t represents the unglycosylated form of F1 as no mobility change was observed on digestion of F1 with glycopeptidase F (Fig. 4 ). This unglycosylated polypeptide would then undergo some modification resulting in a polypeptide ( F i t ) with an increased mobility.
In Fig. 8 the 12K polypeptide (and possibly the 20K polypeptide) show increased label incorporation during the chase periods. However, this does not correlate with the shift from F0t to F 1 t. The 12K polypeptide shows a similar increase in label incorporation during chase periods in the absence of tunicamycin when there is no change in the mobility of the F1 protein. The 12K protein therefore does not behave as an F2-1ike protein.
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Fl-related polypeptides identified under non-reducing conditions
The behaviour of Fl-related proteins under non-reducing conditions has been studied to identify a homologue of the F1,2 polypeptide of other paramyxoviruses. This consists of the disulphide-bonded F1 and F2 proteins and has a similar mobility to the uncleaved F0 protein.
[3H]Glucosamine labelling and immunoprecipitation of polypeptides expressed on the cell surface were used to identify the F-related proteins. The RS virus F protein was detected mainly as F1 and F2 under reducing conditions (Fig. 9a) . A small amount of F0 was precipitated from RS virus-infected cell lysates. Under non-reducing conditions most of the label was present in F1,2 with some in higher mobility bands.
Under non-reducing conditions the PVM F1 protein band was slightly reduced in intensity (Fig. 9a and b (Table 1) . Unlike RS virus but like the other paramyxoviruses, PVM has haemagglutinating activity with murine erythrocytes and the G1/G2 glycoprotein appears to be the haemagglutinin since a MAb to this protein inhibits haemagglutination. The antibody does not neutralize PVM so if the large glycoprotein of PVM is the attachment protein as is the case for other paramyxoviruses, attachment to productively infected cells may involve a site on the protein different to that involved in attachment to erythrocytes.
The kinetics of synthesis of the G1/G2 protein appear to differ from those of all the other paramyxoviruses that have been described. Differences between our results and those reported for RS virus do not appear to be due to different experimental systems since the kinetics of synthesis of the RS virus G protein under our conditions are similar to those reported by Fernie et al. (1985) and Gruber & Levine (1985) (C. Caravokyri, personal communication) .
There are two forms of the PVM G glycoprotein, G2 probably being derived from the lower mobility G1 polypeptide. This conversion appears to be a late event in processing, since G2 was not detected until several hours after pulse-labelling. Alternatively G1 and G2 may arise independently, G1 appearing to decrease in intensity due to competition with G2 for the antibody used to immunoprecipitate the samples. G 1 may be derived from a precursor that has not been identified possibly due to failure of antibodies to bind to it, since a change in the reactivity with MAbs of the HN glycoprotein of mumps virus, Newcastle disease virus and Sendai virus has been observed during HN maturation (Mottet et al., 1986; Nishikawa et al., 1986; Yamada et al., 1988) . G2 may have a lesser degree of O-linked glycosylation than G1. The RS virus G protein exists in two forms but the smaller form is soluble (Hendricks et al., 1988) whereas G1 and G2 of PVM are virion proteins (Cash et al., 1979) .
It is not clear whether the PVM F protein is processed in the same way as that of other paramyxoviruses. The results of pulse-chase experiments and experiments carried out under reducing and non-reducing conditions may be interpreted in two ways. There may be an F0 protein that is cleaved too rapidly to allow its detection in pulse-chase experiments except when glycosylation is inhibited by tunicamycin (Fig. 8) . By analogy with other paramyxoviruses F0 would be the same size as the F1,2 protein detected under non-reducing conditions, the latter would comprise the disulphide-bonded F1 and F2 proteins. No F2 protein has been detected, but since it would have an Mr of only 5000 its detection would be difficult. Alternatively F1 may be the only F-related protein synthesized in ihfected cells and may be unstable in the absence of N-linked glycosylation. The two forms of F1 observed under non-reducing conditions (Fig. 9) could be due to different arrangements of intramolecular disulphide bonds. The function of the F1 protein is unknown since syncytium formation is rarely observed during infection of cell monolayers with PVM, although it is possible that fusion of infected cells occurs in vivo.
